Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Bone & Joint Health Supplements Market

Bone & Joint Health Supplements Market Analysis

  • Report ID: GMI7684
  • Published Date: Dec 2023
  • Report Format: PDF

Bone & Joint Health Supplements Market Analysis 

Based on product, the market is classified as vitamins & minerals, collagen, glucosamine-chondroitin, omega-3 fatty acid, and other products. In 2023, vitamins & minerals segment accounted for a significant market share of 50.1%.

 

  • Vitamins & minerals such as calcium, vitamin D, vitamin K, magnesium, phosphorus, and others play are fundamental nutrients in bone formation, mineralization, and overall bone health. Their importance in maintaining strong bones and joints positions them as foundational components of bone health supplements.

     

  • The vitamin & mineral products are easily accessible and affordable, making them more widely available to a diverse consumer base. Additionally, the advantages such as improved bone density, enhanced joint function, inflammation reduction, and a lowered risk of fractures.

     

Based on form, the global bone & joint health supplements market is segmented into capsules & tablets, powders, liquids, and other forms. The capsules & tablets segment dominated the market and is expected to register progrssion of 8.1% by 2032.
 

  • Capsules and tablets generally have a longer shelf life compared to other dosage forms. It reduces the likelihood of product degradation over time and allows for extended storage. In addition to this, the factors such as convenience, ease of consumption, accuracy in dosage, stability, manufacturing efficiency, and positive consumer perception.
     

Based on consumer, the market is divided into geriatric population, adults, pregnant women, children, and infants. The geriatric population segment is expected to reach USD 8.9 billion by 2032.
 

  • Aging is often accompanied by a higher prevalence of bone and joint health issues such as osteoporosis, arthritis, and general joint stiffness. Also, bone and joint health supplements are seen as proactive measures to prevent or alleviate conditions associated with aging.
     
Bone & Joints Health Supplements Market Share, By Distribution Channel (2023)

Based on distribution channel, the global bone & joint health supplements market is categorized into pharmacies, brick & mortar, e-commerce, and other distribution channels. The pharmacies segment is anticipated to witness expansion at 7.9% during the analysis period to reach USD 10 billion by 2032.
 

  • Pharmacies typically offer a wide range of healthcare products, including various bone and joint health supplements. This diversity allows consumers to choose from different brands, formulations, and price points, meeting individual preferences and needs.
     
  • Furthermore, the presence of licensed pharmacists and adherence to regulatory standards contribute to the credibility of products available in pharmacies, assuring consumers safety.
     
U.S. Bone & Joint Health Supplements Market Size, 2021- 2032 (USD Billion)

The North America bone & joint health supplements market accounted for USD 5.2 billion in 2023.
 

  • North America comprises significant aging population. With the growing geriatric population, there is a higher prevalence of bone and joint health issues such as osteoporosis and arthritis.
     
  • Moreover, few of the other factors that boosts the regional gains includes well-established healthcare systems, presence of key market players, consumer awareness and increased adoption of supplements.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for bone & joint health supplements was valued at USD 13.6 billion in 2023 and is anticipated to observe over 7.5% CAGR from 2024 to 2032 attributed to the increasing ageing population and the rising prevalence of bone-related disorders.

The vitamins & minerals segment accounted for a significant market share of 50.1% in 2023 and will grow significantly through 2032 as they are easily accessible and affordable, making them more widely available to a diverse consumer base.

North America market size was USD 5.2 billion in 2023 and is expected to expand by 2032 with the growing geriatric population along with the higher prevalence of bone and joint health issues, such as osteoporosis and arthritis.

Bayer AG, Amway, BASF SE, Vita Life Sciences Ltd, Glanbia plc, Arazo Nutrition, Reckitt Benckiser Group plc, Nature's Bounty, Inc., NOW Foods, and GNC Holdings, LLC.

Bone & Joint Health Supplements Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 270
  • Countries covered: 19
  • Pages: 150
 Download Free Sample